In a phase 2 trial, use of the novel oral antiandrogen apalutamide shows promise in patients with very low- to intermediate-risk prostate cancer on active surveillance.
Use of computed tomography and bone scans in low-risk prostate cancer cases has been in decline, but doctors continue to order these imaging modalities despite professional guidelines that do not recommend such use.
New findings suggest preoperative CKD stage should be incorporated into risk stratification algorithms for patients undergoing radical cystectomy, according to investigators.
Among men with high-risk prostate cancer, delaying radical prostatectomy for up to 12 months is not associated with an increased risk for adverse pathology at the time of surgery compared with those who undergo immediate RP, a study found.
In a subgroup analysis, neither patient characteristics nor prior treatment history influenced response to a novel intravesical gene therapy for BCG-unresponsive bladder cancer.
Patients who received BCG induction within 3 weeks or 3 weeks or more after surgery for nonmuscle-invasive bladder cancer did not differ in their rates of BCG intolerance and recurrence- and progression-free survival, a study found.
PSA density is routinely collected as part of prostate cancer active surveillance protocols, so monitoring kinetics confers no extra costs or burdens on patients, according to investigators.
Higher proportions of patients in the low to middle income brackets were diagnosed with localized renal cell carcinoma in states allowing Medicaid expansion.
A study of patients with metastatic renal cell carcinoma showed that patients with and without bone metastases have similar progression-free and overall survival.
Patients with nonmuscle-invasive bladder cancer who received intravesical chemotherapy after transurethral resection of bladder tumor had a significantly lower 30-day complication rate compared with those who did not receive intravesical chemotherapy.
Understanding causes of death in contemporary patients with prostate cancer is essential for proper survivorship management, according to investigators.
Many patients with PI-RADS 5 lesions on multiparametric MRI scans, which indicates a very high likelihood of clinically significant prostate cancer, have negative findings on standard template biopsy, investigators reported.
Women were approximately 1.7 and 3.0 times more likely than men to experience recurrence and progression, respectively, following BCG treatment for nonmuscle-invasive bladder cancer.
